Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3…
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical…
Merus Announces FDA Approval of BIZENGRI (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ NonSmall Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
BIZENGRI® is the first and only therapy approved by the FDA specifically…
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX),…
Asia’s Transformative Era: Unveiling the “Asian Dream” through New Study “Truth About Ascending Asia”
SINGAPORE, Dec. 4, 2024 /PRNewswire/ -- McCann Worldgroup has launched its latest…
New Biovanta Study Shows Best Efficacy in Treating Common Cold
Newcomer to OTC cold market offers clinically proven alternative with anti-inflammatory and…
Xinhua Silk Road: Yucun Village in E China’s Zhejiang releases study tour brand to promote upgrade of study tour industry
BEIJING, Dec. 2, 2024 /PRNewswire/ -- The Grand Opening Ceremony of Great Yucun…
MapmyGenome Unveils Groundbreaking Study on Genetic Variants Linked to Longevity in Long-Living Indians
HYDERABAD, India, Nov. 22, 2024 /PRNewswire/ -- MapmyGenome, a leader in genetic…
Lingokids Demonstrates Effective Child Learning in Just 8 Weeks: Results from an Efficacy Study
Improvements of 6% in literacy, 7% in math, and 10% in socio-emotional…
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
November 20, 2024 16:30 ET | Source: Sirona Biochem Corp. VANCOUVER, British…